Liver Screening for GP Practices
Screen patients for liver disease without referral delays. With Elastography Australia, you can integrate liver health assessment into routine checkups and chronic disease management, providing immediate results and better patient outcomes.
Challenges We Solve
We understand your challenges
Referral Delays
Patients wait months for specialist appointments and hospital-based FibroScans, delaying critical diagnoses and treatment decisions.
Limited Screening Tools
Blood tests provide limited information. Without in-clinic assessment, early-stage liver disease often goes undetected.
Rising MAFLD Prevalence
With obesity rates climbing, more patients need liver screening but access to elastography remains limited in primary care.
Revenue Pressure
GP practices face ongoing financial pressures while specialists capture most procedural revenue from liver assessment.
Patient Experience
Multiple appointments across different facilities creates friction and reduces patient compliance with screening recommendations.
Care Continuity
When patients are referred out, GPs lose visibility into results and may miss opportunities for early intervention.
Seamless Integration
Fits your clinical workflow
Routine Health Checks
Integrate liver assessment into your standard health assessments for at-risk patients.
- 1Identify patients with risk factors such as obesity, diabetes, alcohol use, or viral hepatitis.
- 2Perform an Elastography Australia scan during the appointment in around two minutes.
- 3Review the result immediately with the patient and explain the next step.
- 4Document findings and create a management plan or referral pathway.
- 5Use repeat testing to track response to weight loss and metabolic treatment.
Chronic Disease Management
Monitor liver health as part of diabetes, metabolic syndrome, or obesity management.
- 1Include liver screening in chronic disease reviews for high-risk cohorts.
- 2Track liver stiffness over time with serial measurements.
- 3Correlate results with HbA1c, lipids, and weight trends.
- 4Adjust treatment plans based on liver health findings.
- 5Demonstrate lifestyle intervention impact to patients in a tangible way.
Return on Investment
The business case is clear
Australians estimated to be living with MAFLD
Median examination time in comparative research
Not years for clinics with steady scan demand
Key ROI Factors
Portable point-of-care workflow with minimal setup.
Supports the FIB-4 to elastography pathway for indeterminate results.
One universal probe simplifies training and scheduling.
Keep screening and follow-up inside the clinic.
Matches the move toward community-based liver risk stratification.
Creates a differentiated service line in general practice.
Adding Elastography Australia to our practice has transformed how we manage metabolic patients. We can now screen everyone at risk, intervene earlier, and patients love getting results on the spot.
Ready to transform your practice?
Join leading Australian clinicians who have already made the switch to guided liver elastography.